Myovant Sciences Ltd is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its product candidate is relugolix.
Stock Price Prediction
Update at 5:00pm EST
12.018 - 12.102
12.102 - 12.166
10.951 - 11.059
11.059 - 11.142
11.554 - 11.707
11.707 - 11.824
as of: 2020-02-14 4:30:57 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.MYOV has closed above bottom band by 1.3%. Bollinger Bands are 56.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to MYOV's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
2020-02-10 Stock To Watch: Myovant Sciences (MYOV) Myovant Sciences' (MYOV) phase III LIBERTY extension study of once-daily Relugolix combination therapy in women with uterine fibroids has yielded encouraging results.
2019-12-30 Myovant Sciences Confirms Closing of US$400 Million Loan Facility Myovant confirmed the closing of the previously announced loan facility from Sumitomo Dainippon Pharma, now increased to US$400 million. The post Myovant Sciences Confirms Closing of US$400 Million Loan Facility appeared first on Investing News Network .
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.